Covid-19 roundup: Mod­er­na CEO Stéphane Ban­cel be­comes a bil­lion­aire; No­var­tis, In­cyte pitch Jakafi PhI­II to tack­le se­vere cas­es

You can now add Mod­er­na CEO Stéphane Ban­cel to the list of biotech bil­lion­aires.

Since in­vestors be­gan to un­der­stand the full scope of the coro­n­avirus out­break in late Feb­ru­ary, cash has flushed out of much of the stock mar­ket and in­to the hand­ful of com­pa­nies lead­ing the fight for drugs and vac­cines. That’s meant hun­dreds of mil­lions for Mod­er­na, the Flag­ship-backed com­pa­ny that emerged ear­ly as the world’s first best hope for a Covid-19 vac­cine.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.